Menu

Latest Pharma Insights


Apollo Endosurgery nets $19.4mm via FOPO
Apollo Endosurgery Inc. (minimally invasive devices for bariatric and gastrointestinal procedures) netted $19.4mm through a follow-on public offering of 3.75mm common shares at $5.50 each.
Strategic Transactions - June 22, 2018
Access To Widely Scattered Data A Major Challenge For Evolving Health Care Industry: EY Report
There is a tremendous opportunity to use available data to improve health care, EY concludes, but life sciences companies must...
The Pink Sheet - June 22, 2018
Incyte Will File Jakafi For Acute GVHD In US Based On Phase II Success
The JAK1/2 inhibitor may add an indication for acute graft-versus-host disease, though based on a single, open-label Phase II trial...
The Pink Sheet - June 22, 2018
QUOTED. June 25, 2018. Dennis Durmis.
Imaging equipment firms and other device-makers are lobbying Congress for more FDA controls over companies that perform third-party maintanence of...
Medtech Insight - June 22, 2018
C-Suite Changes At J&J
Sandra Peterson is retiring as worldwide chairman of J&J after about five years in the post; several other executives moved...
Medtech Insight - June 22, 2018
With 5-0 Winning Streak, Bayer And J&J Move To Eliminate Remaining Xarelto Litigation
Firms want Fifth Circuit to review whether federal law preempts failure-to-warn and design-defect claims; ruling in their favor could end...
The Pink Sheet - June 22, 2018
Industry May Like FDA's Biosimilar Guidance Withdrawal, But Not The New Information Vacuum
Sponsors may have to rely even more on the advice they receive from formal meetings as FDA decides to rewrite...
The Pink Sheet - June 22, 2018
Device Week, June 22, 2018 – FDA Guidance And The MTI Awards
On this week's podcast, we provide a roundup of recent guidance documents issued by US FDA on topics ranging from...
Medtech Insight - June 22, 2018
CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors
INTERACT program will allow sponsors to ask FDA questions about manufacturing and other technical issues to help streamline development.
The Pink Sheet - June 22, 2018
Emerson Offers E-Commerce To Help Health Care Practitioners Continue Selling Supplements
At least one-third of consumers who have bought supplements from health care providers currently are buying the products online, with...
The Rose Sheet - June 22, 2018
CFI Announces Gov-Supported Program To Streamline China Entry Without Animal Testing
NGO has partnered with Shanghai-based consultancy Knudsen&Co, with the support of Chinese authorities, for a pilot program to shepherd foreign...
The Rose Sheet - June 22, 2018
Boston Scientific Wins Pelvic Mesh Bellwether
A Massachusetts jury has ruled that Boston Scientific is not at fault for adverse events experienced by a woman implanted...
Medtech Insight - June 22, 2018
Siemens Take On Obesity Imaging Challenges With New Ultrasound System
Siemens Healthineers is introducing a new ultrasound system, the Acuson Sequoia, which has been developed to enable high-resolution imaging at...
Medtech Insight - June 22, 2018
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Pink Sheet - June 22, 2018
US FDA May Prioritize Pediatric Cancer Studies By Level Of 'Substantial Relevance'
Assessing the extent of a molecular target's substantial relevance to pediatric cancer could give sponsors more regulatory certainty as to...
The Pink Sheet - June 22, 2018
Canada’s Animal-Testing Ban Would Require Authorizations For Last Resort Studies
Four years after enactment, Canada’s proposed legislation – which passed the Senate June 19 – would prohibit the sale of...
The Rose Sheet - June 22, 2018
Dealing With Brexit: EMA Offers Firms Advice On More Thorny Questions
The European Medicines Agency has updated its guidance on Brexit to offer companies more advice on the regulatory changes they...
The Pink Sheet - June 22, 2018
Venezuela Shuns ‘Multinational Pharmaceutical Cartel’ And Turns To Pan American Health Organization
Venezuela has accused the pharmaceutical industry of holding up medicines supplies and says it will acquire them instead through the...
The Pink Sheet - June 22, 2018
Interview: EULAR Head Counting The Cost Of Rheumatic Disease
Hans Bijlsma, president of the European League Against Rheumatism, tells Scrip about the progress being made in rheumatic and muskuloskeletal...
The Pink Sheet - June 22, 2018
Market Intel: Peripheral Nerve Stim Players Edge Out Innovative Paths
While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small...
Medtech Insight - June 22, 2018
Bills Calling For Non-Pharma Alternatives To Opioids Clear US House
Several bills that try to lift barriers to development and use of device alternatives for pain management in response to...
Medtech Insight - June 22, 2018
Mexico Simplifies Digital Advertising Guidelines
A recent guidance document from Mexican medical device regulator COFEPRIS simplifies the agency’s recommendations for online promotion of medical devices.
Medtech Insight - June 22, 2018
QUOTED. June 22, 2018. Amanda Micklus.
Roche bought out Foundation Medicine in full. Check out what Datamonitor Health analyst Amanda Micklus says about how the deal...
Medtech Insight - June 22, 2018

Interview: Eisai India Unit’s Pivotal Role As Japan Genericizes
Eisai India chief Dr. Sanjit Singh Lamba outlines the competitive edge that the Japanese group’s Indian site offers under the...
Scrip - June 21, 2018
GC-Yuhan Orphan Alliance Signals Changing Korean Views On Open Innovation
In what appears to be the first open innovation-based partnership between leading South Korean pharma firms, GC Pharma and Yuhan...
Scrip - June 21, 2018
The Blockbusters No One Talks About
Drugs like Nexium, Lipitor, Lovenox and Plavix lost patent protection years ago, but continue to generate blockbuster level sales. Here's...
Scrip - June 21, 2018
Tech Transfer Roundup: Amgen Teams With MD Anderson To Accelerate Early-Stage Cancer Candidates
In a busy month, MD Anderson also partners with Ipsen on an unspecified cancer drug and licenses poziotinib IP to...
Scrip - June 21, 2018
Addressing eClinical Data Challenges
Scrip - June 21, 2018
Ipsen CEO: 'I Assume a Hard Brexit', But Remain Bullish On UK Life Sciences
Ipsen's David Meek tells Scrip a Hard Brexit looks likely and that he's preparing the French pharma for that scenario.
Scrip - June 21, 2018
Learning From Human Cell Hijacking Masters: ENYO Pharma Takes Virus Tricks Into Drug Discovery
Emerging Company Profile: ENYO Pharma has been around for barely four years, but it is already advancing its lead programs...
Scrip - June 21, 2018
Appointments: Sanofi, Celgene, TeGenix, Allogene, Aimmune, TikoMed and Ionis Announce Changes At The Top
This week's appointments include a new CFO at Sanofi,  a new general counsel at Celgene plus new hires at TiGenix...
Scrip - June 21, 2018
Alexion Gets Speedy Review For Soliris Successor
Switching patients from the very expensive ultra rare disorder drug to ravulizumab will be a key strategy for Alexion if...
Scrip - June 21, 2018

Access To Widely Scattered Data A Major Challenge For Evolving Health Care Industry: EY Report
There is a tremendous opportunity to use available data to improve health care, EY concludes, but life sciences companies must...
The Pink Sheet - June 22, 2018
Incyte Will File Jakafi For Acute GVHD In US Based On Phase II Success
The JAK1/2 inhibitor may add an indication for acute graft-versus-host disease, though based on a single, open-label Phase II trial...
The Pink Sheet - June 22, 2018
With 5-0 Winning Streak, Bayer And J&J Move To Eliminate Remaining Xarelto Litigation
Firms want Fifth Circuit to review whether federal law preempts failure-to-warn and design-defect claims; ruling in their favor could end...
The Pink Sheet - June 22, 2018
Industry May Like FDA's Biosimilar Guidance Withdrawal, But Not The New Information Vacuum
Sponsors may have to rely even more on the advice they receive from formal meetings as FDA decides to rewrite...
The Pink Sheet - June 22, 2018
CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors
INTERACT program will allow sponsors to ask FDA questions about manufacturing and other technical issues to help streamline development.
The Pink Sheet - June 22, 2018
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Pink Sheet - June 22, 2018
US FDA May Prioritize Pediatric Cancer Studies By Level Of 'Substantial Relevance'
Assessing the extent of a molecular target's substantial relevance to pediatric cancer could give sponsors more regulatory certainty as to...
The Pink Sheet - June 22, 2018
Dealing With Brexit: EMA Offers Firms Advice On More Thorny Questions
The European Medicines Agency has updated its guidance on Brexit to offer companies more advice on the regulatory changes they...
The Pink Sheet - June 22, 2018
Venezuela Shuns ‘Multinational Pharmaceutical Cartel’ And Turns To Pan American Health Organization
Venezuela has accused the pharmaceutical industry of holding up medicines supplies and says it will acquire them instead through the...
The Pink Sheet - June 22, 2018
Interview: EULAR Head Counting The Cost Of Rheumatic Disease
Hans Bijlsma, president of the European League Against Rheumatism, tells Scrip about the progress being made in rheumatic and muskuloskeletal...
The Pink Sheet - June 22, 2018

Brits Lead Charge In Global Battle Against Antimicrobial Resistant Superbugs
During the annual BIO International conference in June, researchers from the UK – which has pushed antimicrobial resistance to front...
IN VIVO - June 20, 2018
Pharma’s New R&D Models: Federating Innovation
Experiments are underway to solve pharma’s well-documented R&D productivity crisis. The industry is no longer focused only on buying new...
IN VIVO - June 20, 2018

QUOTED. June 25, 2018. Dennis Durmis.
Imaging equipment firms and other device-makers are lobbying Congress for more FDA controls over companies that perform third-party maintanence of...
Medtech Insight - June 22, 2018
C-Suite Changes At J&J
Sandra Peterson is retiring as worldwide chairman of J&J after about five years in the post; several other executives moved...
Medtech Insight - June 22, 2018
Device Week, June 22, 2018 – FDA Guidance And The MTI Awards
On this week's podcast, we provide a roundup of recent guidance documents issued by US FDA on topics ranging from...
Medtech Insight - June 22, 2018
Boston Scientific Wins Pelvic Mesh Bellwether
A Massachusetts jury has ruled that Boston Scientific is not at fault for adverse events experienced by a woman implanted...
Medtech Insight - June 22, 2018
Siemens Take On Obesity Imaging Challenges With New Ultrasound System
Siemens Healthineers is introducing a new ultrasound system, the Acuson Sequoia, which has been developed to enable high-resolution imaging at...
Medtech Insight - June 22, 2018
Market Intel: Peripheral Nerve Stim Players Edge Out Innovative Paths
While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small...
Medtech Insight - June 22, 2018
Bills Calling For Non-Pharma Alternatives To Opioids Clear US House
Several bills that try to lift barriers to development and use of device alternatives for pain management in response to...
Medtech Insight - June 22, 2018
Mexico Simplifies Digital Advertising Guidelines
A recent guidance document from Mexican medical device regulator COFEPRIS simplifies the agency’s recommendations for online promotion of medical devices.
Medtech Insight - June 22, 2018
QUOTED. June 22, 2018. Amanda Micklus.
Roche bought out Foundation Medicine in full. Check out what Datamonitor Health analyst Amanda Micklus says about how the deal...
Medtech Insight - June 22, 2018

Emerson Offers E-Commerce To Help Health Care Practitioners Continue Selling Supplements
At least one-third of consumers who have bought supplements from health care providers currently are buying the products online, with...
The Rose Sheet - June 22, 2018
CFI Announces Gov-Supported Program To Streamline China Entry Without Animal Testing
NGO has partnered with Shanghai-based consultancy Knudsen&Co, with the support of Chinese authorities, for a pilot program to shepherd foreign...
The Rose Sheet - June 22, 2018
Canada’s Animal-Testing Ban Would Require Authorizations For Last Resort Studies
Four years after enactment, Canada’s proposed legislation – which passed the Senate June 19 – would prohibit the sale of...
The Rose Sheet - June 22, 2018

Apollo Endosurgery nets $19.4mm via FOPO
Apollo Endosurgery Inc. (minimally invasive devices for bariatric and gastrointestinal procedures) netted $19.4mm through a follow-on public offering of 3.75mm common shares at $5.50 each.
Strategic Transactions - June 22, 2018
Back to the top Back to the top